Related Experiment Videos
Oral fluconazole for vaginal candidiasis
1Hamot Family Practice Residency Program, Hamot Medical Center, Erie, Pennsylvania, USA.
Abstract:
The recent surge of interest in fluconazole is due to its approval by the U.S. Food and Drug Administration for use as a single 150-mg oral dose in the treatment of vaginal candidiasis. Fluconazole is a triazole antifungal agent that acts primarily by inhibiting sterol synthesis in the fungal cell membrane. Recent studies have shown that a single dose of oral fluconazole is as effective as intravaginal antifungal agents. Many physicians and patients prefer this single-dose regimen because of its low rate of side effects, cost-effectiveness and ease of administration.
Insights
A single oral dose of fluconazole effectively treats vaginal candidiasis. This antifungal medication is preferred for its safety, cost-effectiveness, and ease of use.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Vaginal candidiasis is a common fungal infection.
- Fluconazole is a triazole antifungal agent.
- The U.S. Food and Drug Administration recently approved fluconazole for treating vaginal candidiasis.
Purpose of the Study:
- To evaluate the efficacy and preference of a single oral dose of fluconazole for vaginal candidiasis.
Main Methods:
- Review of recent studies comparing single-dose oral fluconazole with intravaginal antifungal agents.
Main Results:
- Single-dose oral fluconazole demonstrates comparable efficacy to intravaginal treatments.
- Physicians and patients favor the oral fluconazole regimen.
Conclusions:
- Single-dose oral fluconazole is an effective and preferred treatment for vaginal candidiasis.
- Advantages include a low side effect profile, cost-effectiveness, and simple administration.